Skip to main content
Pharmadrug Inc. logo

Pharmadrug Inc. — Investor Relations & Filings

Ticker · PHRX ISIN · CA71716W2040 LEI · 529900PHQPAWL5ITEB39 CSE Manufacturing
Filings indexed 475 across all filing types
Latest filing 2024-11-26 Regulatory Filings
Country CA Canada
Listing CSE PHRX

About Pharmadrug Inc.

https://pharmadrug.ca/

Pharmadrug Inc. is a specialty pharmaceutical company focused on the research, development, and commercialization of controlled-substances and natural medicines. The company's primary focus areas include the clinical development of reformulated natural-based medicines aimed at treating unmet needs in oncology and infectious diseases. Additionally, Pharmadrug develops synthetic and biosynthetic formulations of existing drugs, specifically addressing opportunities related to the potential third wave of drug policy reform concerning controlled substances.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2024-11-26 English
News release - English.pdf
Regulatory Filings
2024-11-15 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2024-11-07 English
Interim MD&A - English.pdf
Regulatory Filings
2024-11-07 English
Interim financial statements/report – English.pdf
Regulatory Filings
2024-11-07 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the proposed issuance of debenture units and warrants by PharmaDrug Inc. It details the terms of the debentures, maturity, conversion price, and warrants, as well as background information about the company. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is an update on the company's financing activities, specifically about issuing debt instruments and related warrants. It is not an annual or interim report, audit report, or earnings release. It fits the category of Capital/Financing Update, as it provides information on fundraising and capital structure changes.
2024-10-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.